© 2025 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Incunabulum LLC.
Rescheduling’s Fine Print: DEA Becomes Mandatory Middleman
The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.
Notes From the Other New Industry
AI arrived wearing a suit, and cannabis arrived wearing tie-dye. It’s time we talk about why American capital is more responsive to costume than risk.
Hemp D-Day: Preparing for the 2026 ‘Hemp-Killing Clause’
A significant shift in federal law via H.R. 5371 threatens to recriminalize most hemp-derived THC products by November 12, 2026. Dubbed the “hemp-killing clause,” this provision sets a 0.4mg total THC cap per container, potentially turning compliant businesses into “real estate time bombs.” From auditing leases to negotiating early termination rights, two attorneys tackle how hemp tenants and landlords can navigate the looming regulatory crisis and protect their commercial interests before the “Hemp D-Day” deadline.
How Cannabis Businesses Should Prepare for a Potential End to 280E
A potential move of cannabis to Schedule III could eventually reshape the industry’s tax burden by ending the reach of Section 280E. But operators should not confuse political momentum with immediate relief. A CPA explains why retroactive tax refunds are unlikely and disciplined compliance still matters. From defensible cost accounting to scenario planning and entity-structure review, the smartest path is cautious preparation rather than reactive change.
ASA Warns of ‘Access Crisis’ Ahead of 2026 Hemp Changes
According to a new report from Americans for Safe Access, impending federal changes to hemp definitions could strip access from veterans, seniors, and those with rare diseases who rely on full-spectrum products.
After Schedule III: The Hidden Costs of Cannabis Legitimacy
Rescheduling may bring long-awaited 280E relief and a new sheen of mainstream legitimacy, but it also opens the door to federal-grade oversight, GMP expectations, stricter lender requirements, and expanded liability exposure. The “extra” cash operators anticipate could be quickly absorbed by compliance upgrades, professional services, and risk management. For CEOs, COOs, and CFOs, reclassification isn’t a finish line. It’s the starting gun for a tougher operational race.
